FDA says 25 to 27 companies affected by antibiotic phase-out
Dec 11 (Reuters) - The U.S. Food & Drug Administration said on Wednesday that 25 to 27 companies will be affected by the voluntary three-year phase-out of the use of antibiotics in the raising of animals for food production.
The use of tetracyclines, penicillins and macrolides will be most affected, William Flynn, deputy director for science policy at the Center for Veterinary Medicine at the FDA, said during a call with reporters. Zoetis Inc and Eli Lilly & Co's Elanco unit sell a large percentage of those products, he said.
- Search resumes for hundreds missing in South Korean ferry disaster |
- Separatists take armored vehicles, humiliating Ukraine forces |
- Ocean floor search for missing Malaysia plane cut short again
- BofA reports first quarterly loss since 2011 on lofty legal bill
- Ukraine launches 'gradual' operation, action limited |